Stay updated on Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now presents the study record for nivolumab plus ipilimumab in thyroid cancer, with detailed trial methods, participant criteria, results measures, and supporting documents.
    Difference
    73%
    Check dated 2026-11-11T01:17:49.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the study record is still inaccessible on the page.
    Difference
    0.2%
    Check dated 2026-11-03T23:32:05.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page. The site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:23:36.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The error page’s revision identifier changed from v3.7.0 to v3.7.1, while it continues to display a 403 Forbidden response.
    Difference
    0.2%
    Check dated 2026-10-07T00:34:28.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page with a minimal header and a Home link, replacing the previous detailed study information and documents. This blocks access to the study record and its associated materials.
    Difference
    22%
    Check dated 2026-09-23T00:32:36.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, signaling a new build of the Study Details page rather than a change to the study information.
    Difference
    0.0%
    Check dated 2026-09-15T23:44:49.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page.